Design Therapeutics (DSGN) Accumulated Depreciation & Amortization (2020 - 2026)

Design Therapeutics' Accumulated Depreciation & Amortization history runs 7 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• In Q1 2026, Accumulated Depreciation & Amortization rose 34.28% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $2.4 million (up 34.28% YoY), while the FY2025 annual figure was $2.3 million, up 36.8% from the prior year.
• Accumulated Depreciation & Amortization came in at $2.4 million for Q1 2026 at Design Therapeutics, up from $2.3 million in the prior quarter.
• In the past five years, Accumulated Depreciation & Amortization ranged from a high of $2.4 million in Q1 2026 to a low of $197000.0 in Q1 2022.
• A 5-year average of $1.2 million and a median of $1.2 million in 2024 frame the typical range for Accumulated Depreciation & Amortization.
• Across the five-year window, Accumulated Depreciation & Amortization jumped 2088.89% in 2022 and soared 34.28% in 2026, its largest moves.
• Design Therapeutics' Accumulated Depreciation & Amortization stood at $522000.0 in 2022, then jumped by 102.87% to $1.1 million in 2023, then soared by 56.28% to $1.7 million in 2024, then soared by 36.8% to $2.3 million in 2025, then advanced by 6.93% to $2.4 million in 2026.
• According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $2.4 million, $2.3 million, and $2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison